Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature

MeSH terms

• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use
• Biomarkers
• Bone Marrow / pathology
• Eosinophilia / pathology*
• Gene Rearrangement
• Humans
• Imatinib Mesylate / adverse effects*
• Imatinib Mesylate / therapeutic use
• Leukemia, Myeloid / complications*
• Leukemia, Myeloid / diagnosis
• Leukemia, Myeloid / drug therapy
• Leukemia, Myeloid / genetics*
• Protein Kinase Inhibitors / adverse effects
• Protein Kinase Inhibitors / therapeutic use
• Receptor, Platelet-Derived Growth Factor alpha / genetics*
• Tumor Lysis Syndrome / diagnosis*
• Tumor Lysis Syndrome / etiology*